BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lukacs NW, Malinczak CA. Harnessing Cellular Immunity for Vaccination against Respiratory Viruses. Vaccines (Basel) 2020;8:783. [PMID: 33371275 DOI: 10.3390/vaccines8040783] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Sabitha S, Shobana N, Prakash P, Padmanaban S, Sathiyashree M, Saigeetha S, Chakravarthi S, Uthaman S, Park I, Samrot AV. A Review of Different Vaccines and Strategies to Combat COVID-19. Vaccines 2022;10:737. [DOI: 10.3390/vaccines10050737] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Smatti MK, Alkhatib HA, Al Thani AA, Yassine HM. Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents. Front Med 2022;9:802312. [DOI: 10.3389/fmed.2022.802312] [Reference Citation Analysis]
3 Naskalska A, Dabrowska A, Szczepanski A, Jasik KP, Gromadzka B, Pyrc K. Functional Severe Acute Respiratory Syndrome Coronavirus 2 Virus-Like Particles From Insect Cells. Front Microbiol 2021;12:732998. [PMID: 34745036 DOI: 10.3389/fmicb.2021.732998] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Pogostin BH, McHugh KJ. Novel Vaccine Adjuvants as Key Tools for Improving Pandemic Preparedness. Bioengineering (Basel) 2021;8:155. [PMID: 34821721 DOI: 10.3390/bioengineering8110155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Racine-Brzostek SE, Yee JK, Sukhu A, Qiu Y, Rand S, Barone PD, Hao Y, Yang HS, Meng QH, Apple FS, Shi Y, Chadburn A, Golden E, Formenti SC, Cushing MM, Zhao Z. Rapid, robust, and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals. JCI Insight 2021;6:e151477. [PMID: 34499052 DOI: 10.1172/jci.insight.151477] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
6 Feng C, Shi J, Fan Q, Wang Y, Huang H, Chen F, Tang G, Li Y, Li P, Li J, Cui J, Guo L, Chen S, Jiang M, Feng L, Chen L, Lei C, Ke C, Deng X, Hu F, Tang X, Li F. Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery. Nat Commun 2021;12:4984. [PMID: 34404803 DOI: 10.1038/s41467-021-25312-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 42.0] [Reference Citation Analysis]
7 Racine-brzostek SE, Yee J, Sukhu A, Qiu Y, Rand S, Barone P, Hao Y, Yang HS, Meng QH, Apple FS, Shi Y, Chadburn A, Golden E, Formenti SC, Cushing MM, Zhao Z. More rapid, robust and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals.. [DOI: 10.1101/2021.08.04.21261561] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Tripp RA, Stambas J. Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins. Viruses 2021;13:625. [PMID: 33917411 DOI: 10.3390/v13040625] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Velikova T. INFECTION-ACQUIRED VERSUS VACCINE-INDUCED IMMUNITY AGAINST COVID-19. CAJMHE 2021;2:29-35. [DOI: 10.47316/cajmhe.2021.2.1.05] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
10 Temchura V. Decorated and Encapsulated: Virus-Like Particles Against Viral Infections. Vaccines (Basel) 2021;9:273. [PMID: 33803636 DOI: 10.3390/vaccines9030273] [Reference Citation Analysis]
11 Rosenberg HF, Foster PS. Eosinophils and COVID-19: diagnosis, prognosis, and vaccination strategies. Semin Immunopathol 2021;43:383-92. [PMID: 33728484 DOI: 10.1007/s00281-021-00850-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 18.0] [Reference Citation Analysis]